Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20385233 | 1.00 | ALDH1A1 (0.35) | ALDH1A1TP53HSP90AA1CYP3A4THRB | |
| SCHEMBL7775214 | 0.81 | TSHR (0.35) | ALDH1A1CYP3A4TSHR | |
| SCHEMBL11423476 | 0.81 | GABBR2 (0.34) | ALDH1A1TP53HSP90AA1CYP3A4THRB | |
| SCHEMBL13995799 | 0.81 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL13999372 | 0.81 | TSHR (0.35) | ALDH1A1CYP3A4TSHR | |
| SCHEMBL26084150 | 0.81 | — | — | |
| SCHEMBL26250345 | 0.81 | TSHR (0.40) | ALDH1A1TP53HSP90AA1CYP3A4THRB | |
| SCHEMBL16234248 | 0.79 | — | — | |
| SCHEMBL104096 | 0.79 | — | — | |
| SCHEMBL18327442 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3853219-B1 | HERBICIDALLY ACTIVE SUBSTITUTED PHENYLPYRIMIDINE HYDRAZIDES | BAYER AG (DE) | 2023-07-12 | — | — | EP | disclosed |
| EP-2997075-B1 | NOVEL POLYMER AND THERMOSETTING COMPOSITION CONTAINING SAME | FUJIFILM ELECTRONIC MAT USA INC (US) | 2021-12-15 | — | — | EP | disclosed |
| WO-2021127275-A1 | GSK-3 MODULATOR OTIC FORMULATIONS | OTONONY, INC. (US) | 2021-06-24 | — | — | WO | disclosed |
| WO-2021119554-A1 | COMPOSITIONS AND METHODS FOR POTENTIATING IMMUNE ACTIVITY | KUMQUAT BIOSCIENCES INC. (US) | 2021-06-17 | — | — | WO | disclosed |
| US-20200185625-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-06-11 | — | — | US | disclosed |
| EP-3061866-B1 | PROCESS FOR MAKING PAPER OR PAPERBOARD | KEMIRA OYJ (FI) | 2020-04-29 | — | — | EP | disclosed |
| US-10636983-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-04-28 | — | — | US | disclosed |
| US-10276805-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-04-30 | — | — | US | disclosed |
| EP-0838508-B1 | Aqueous ink composition for use in an ink-jet printer | SEIKO EPSON CORP (JP) | 2001-08-29 | — | — | EP | disclosed |
| US-5871572-A | COLORANT, WATER, A WATER-SOLUBLE ORGANIC SOLVENT, AND PECTIC ACID | SEIKO EPSON CORPORATION (JP) | 1999-02-16 | — | — | US | disclosed |
| EP-0838508-A2 | Aqueous ink composition for use in an ink-jet printer | SEIKO EPSON CORPORATION (JP) | 1998-04-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10276805-B2 | Organic electroluminescent materials and devices | EML4, TYR, CPNE4 | ALDH1A1 2007/4885TP53 2799/4885HSP90AA1 4702/4885 |
| US-20200185625-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, EML4 | ALDH1A1 2220/4885TP53 3108/4885HSP90AA1 4660/4885 |
| US-10636983-B2 | Organic electroluminescent materials and devices | EML4, TYR, CPNE4 | ALDH1A1 2007/4885TP53 2799/4885HSP90AA1 4702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.